Superstring Capital Management LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $102 Billion distributed in 35 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Zai Lab LTD with a value of $6.8B, Cidara Therapeutics Inc with a value of $6.56B, Terns Pharmaceuticals, Inc. with a value of $5.93B, 89bio, Inc. with a value of $5.65B, and Immunovant, Inc. with a value of $5.5B.
Examining the 13F form we can see an increase of $17B in the current position value, from $84.5B to 102B.
Superstring Capital Management LP is based out at New York, NY
Below you can find more details about Superstring Capital Management LP portfolio as well as his latest detailed transactions.